Nightingale’s corporate health service piloted at Mitsui headquarters in Tokyo
18 November 2021 at 9:00 (EET)
Nightingale Health Japan KK, a fully owned subsidiary of Nightingale Health Plc (together “Nightingale”), is organising a pilot for its corporate health service at Japanese conglomerate Mitsui & Co Ltd. (“Mitsui”). The purpose of the pilot is to demonstrate how Nightingale’s wellbeing service can empower employees to take action to improve their daily lifestyle and develop better wellbeing with personal health information. The first phase of the pilot takes place on the 18th and 19th of November 2021, followed by the second phase in December 2021 and the third phase during the first quarter of 2022.
The pilot will consist of on-site blood draws at Mitsui’s headquarter in Tokyo, and the pilot participants will be provided their personal Nightingale blood test results at each phase of the pilot. The participants are encouraged to make positive lifestyle changes based on their results, and participants can easily follow their progress with follow-up tests. In the future, similar services can be provided by utilising Nightingale’s at-home testing solution.
Mitsui is one of the most diversified and comprehensive trading, investment and service enterprises in the world, with 130 offices in 63 countries as of September 2021, and revenue of 72.2 billion USD as of March 2021.
Nightingale considers substantial potential in the international corporate health market as it aims to provide concrete ways for companies to take better care of their employees and Nightingale’s holistic wellbeing solution is a great fit with this market need.
Teemu Suna, CEO and Co-founder of Nightingale:
“There is vast demand for impactful wellbeing solutions that companies can provide to their employees in Japan. The pilot with Mitsui is the first step to expand our Japan offering to companies looking for solutions to enhance employee health management by providing concrete tools for prevention.”
Toshitaka Inuzuka, General Manager, NutriScience Division of Mitsui:
“Nightingale provides an impactful and objective health management solution that supplies employees with tools to monitor and improve their personal health and wellbeing. Workplace health promotion is a megatrend driven by consumers’ increasing interest to manage their health and government-level initiatives to encourage employers’ actions towards healthier workplaces. With the pilot, we are providing our employees early access to a cutting-edge health management technology and we look forward to seeing how the service is received.”
For further information, please contact:
Teemu Suna, CEO
Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. Our wide-ranging disease risk predictions consist of two interconnected factors: Our proprietary blood analysis technology and a large amount of data on health events. We help people make better personal health decisions and connect the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.
Mitsui is one of the most diversified and comprehensive trading, investment and service enterprises in the world, with 130 offices in 63 countries as of September, 2021, and revenue of 72.2 billion USD as of March 2021. Utilizing its global operating locations, network and information resources, Mitsui is multilaterally pursuing business that ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects in the following fields: Wellness, Iron & Steel Products, Mineral & Metal Resources, Infrastructure Projects, Mobility, Chemicals, Energy, Food, Food & Retail Management, IT & Communication Business, Corporate Development Business. Mitsui is actively taking on challenges for global business innovation around the world.
Welltus is a subsidiary company newly established by Mitsui to deliver science-based analysis and solutions to improve health outcomes. The Company leverages Nightingale’s innovative blood test service and customer-friendly way of visualizing health conditions to help people change their long-term habits and thereby live healthier lives. The Company also utilizes Mitsui’s wide range of network and business portfolio especially in health-care and wellness space to create synergy and expand its service rapidly. In April 2021, Welltus and Nightingale announced a service agreement, based on which the parties will launch several new health and well-being services in Japan. Since June 2021, the first service has been piloted in a few selected medical clinics that sell preventative health check-ups to consumers.